Clinical Trial Update: A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating megestrol acetate alone or with testosterone enanthate for HIV-associated weight loss completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• HIV Wasting Syndrome

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• TESTOSTERONE ENANTHATE (TESTOSTERONE ENANTHATE)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, HIV Wasting Syndrome | Phase 2 | Status: COMPLETED